Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001822629-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-02-28 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $73.90 | -12.2K | 421.9K | -3% | -$902.8K | |
| 2026-03-02 | 2026-02-26 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | A - Grant | $77.15 | +75.6K | 434.2K | +21% | +$5.83M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-28 | F | D | 12,217 | $73.90 | 421,949 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-26 | A | A | 75,592 | $77.15 | 434,166 | D | — | — |